
Osteogenesis Imperfecta (Brittle Bone Disease): Symptoms, Diagnosis and Treatment
Osteogenesis imperfecta, commonly called brittle bone disease, is a group of genetic conditions in which bone is unusually fragile and more likely to fracture. It can also affect limb shape, growth, muscle strength, joints, the spine, teeth, hearing and breathing.
Severity varies considerably. Some people have a few fractures and little or no deformity, while others develop recurrent fractures, progressive bowing of the long bones, short stature and restricted mobility. Treatment therefore needs to be based on the individual’s diagnosis, growth, fracture history, alignment, function and wider health.
What Is Osteogenesis Imperfecta?
Bone strength depends on both mineral and an organised protein framework. Type I collagen forms an important part of that framework. In most people with osteogenesis imperfecta, a genetic change reduces the amount of normal type I collagen or alters its structure. Other, less common forms affect collagen processing, bone formation or mineralisation.
The resulting bone may be narrow, thin-corticed, deformed or reduced in mass. Its material properties are also abnormal, so bone mineral density alone does not fully describe fracture risk. A normal or only mildly reduced bone density measurement does not exclude mild osteogenesis imperfecta.
Osteogenesis imperfecta is included within the wider group of genetic skeletal dysplasias, but bone fragility rather than abnormal cartilage growth is its defining feature. It is not the same condition as age-related osteoporosis.
What Causes Osteogenesis Imperfecta?
Most cases are caused by a pathogenic variant in the COL1A1 or COL1A2 gene. These genes provide instructions for making type I collagen. Many other genes can cause less common forms of osteogenesis imperfecta or closely related inherited bone-fragility disorders.
Inheritance is often autosomal dominant, meaning that one altered copy of a gene can cause the condition. The variant may be inherited from an affected parent or arise for the first time in the affected person. Less common forms can be autosomal recessive or X-linked.
Genetic counselling can clarify the likely inheritance pattern, the limits of testing and the implications for other family members or a future pregnancy.
Types of Osteogenesis Imperfecta
Clinical classification remains useful because it describes the person’s overall pattern and severity:
- Type 1 is usually the mildest, non-deforming form. Fractures are more frequent in childhood, blue or grey sclerae may be present, and hearing loss can develop later.
- Type 2 is the severe perinatal form traditionally described as lethal around birth. It is associated with multiple fractures, a small chest and major respiratory compromise. Severe prenatal findings can overlap with survivable forms, so prognosis must be assessed individually rather than assigned from a preliminary label alone.
- Type 3 is progressively deforming. Recurrent fractures, long-bone bowing, very short stature, scoliosis and significant mobility limitations may develop.
- Type 4 has variable, often moderate severity, with fractures and possible deformity but usually normal-coloured sclerae.
- Type 5 has distinctive features that can include excessive callus formation, restriction of forearm rotation and radial-head dislocation.
Additional gene-defined forms are recognised. Clinical types overlap, and two people with the same genetic variant can be affected differently.
Signs and Orthopaedic Effects
Fractures may occur before birth, during delivery, when a child begins to stand and walk, or later in life. The force required to cause a fracture varies with the severity of the condition.
Possible skeletal and functional effects include:
- recurrent fractures following minimal trauma;
- bowing or angulation of the femur, tibia, humerus or forearm;
- vertebral compression and scoliosis;
- short stature or altered body proportions;
- muscle weakness, fatigue and reduced endurance;
- joint hypermobility, instability or contracture;
- pain and difficulty standing, walking or transferring;
- unequal limb lengths following deformity, growth disturbance or previous fractures;
- reduced upper-limb reach or difficulty with self-care.
A leg length discrepancy may be structural, caused by true shortening, or functional, caused by angulation, pelvic tilt or joint contracture. These possibilities need to be separated before treatment is planned.
Osteogenesis imperfecta can also affect tissues outside the limbs. Blue or grey sclerae, dentinogenesis imperfecta affecting the teeth, progressive hearing loss, easy bruising and ligamentous laxity may occur. Severe skeletal deformity and intrinsic collagen abnormalities can contribute to respiratory problems. Some people require surveillance of the craniovertebral junction, where the skull meets the upper cervical spine.
Not every person develops every feature, and the absence of blue sclerae or dental abnormalities does not rule out the condition.
How Is Osteogenesis Imperfecta Diagnosed?
Diagnosis combines clinical assessment, radiographic findings and molecular genetic testing. No single examination result establishes or excludes every form of osteogenesis imperfecta.
Clinical Assessment
The assessment reviews:
- age at first fracture and the circumstances of each injury;
- fracture location, frequency and healing;
- birth, developmental and growth history;
- family history of fractures, hearing loss or similar physical features;
- pain, fatigue, mobility and everyday function;
- dental, hearing, respiratory and neurological concerns;
- previous bisphosphonate treatment or surgery.
Orthopaedic examination considers long-bone bowing, mechanical alignment, limb length, joint stability, rotation, spinal shape, muscle strength and gait. Functional priorities such as standing, transfers, wheelchair use, upper-limb reach and personal care are also important.
Radiographs and Bone Assessment
Radiographs may show thin cortices, slender or bowed bones, fractures of different ages, vertebral compression, reduced mineralisation or small accessory bones within the skull sutures known as Wormian bones. These findings are interpreted in context because none is diagnostic by itself.
Targeted limb radiographs help define a fracture or deformity. Standing full-length lower-limb imaging may be useful when it can be obtained safely. Spine imaging is considered when scoliosis, vertebral compression or neurological concerns are present. CT or MRI may be required for complex deformity or craniovertebral and spinal assessment.
Dual-energy X-ray absorptiometry, or DXA, can monitor bone mineral density. Results must be interpreted with attention to age, growth, body size, vertebral shape and previous treatment. Treatment should not be decided from a DXA value alone.
Genetic and Laboratory Testing
Testing may begin with COL1A1 and COL1A2 or use a broader bone-fragility gene panel. Exome or genome sequencing can be considered when the phenotype overlaps several disorders. A negative result does not automatically exclude osteogenesis imperfecta, particularly when the clinical and radiographic evidence remains persuasive.
Blood investigations may assess calcium, phosphate, alkaline phosphatase, vitamin D and other markers to exclude metabolic or mineralisation disorders. Routine results can be normal in osteogenesis imperfecta.
In a child with unexplained fractures, clinicians must consider inherited bone fragility alongside non-accidental injury and other medical causes. This requires careful multidisciplinary assessment rather than an assumption based on one physical or radiographic feature.
Treatment of Osteogenesis Imperfecta
There is currently no treatment that removes the underlying genetic condition. Management aims to reduce avoidable fractures, preserve movement, control pain, prevent progressive deformity and support participation and independence.
Care may involve a metabolic bone specialist, clinical geneticist, orthopaedic surgeon, physiotherapist, occupational therapist, dentist, hearing specialist, respiratory team and other services according to the person’s needs.
Fracture Care and Rehabilitation
A suspected fracture requires appropriate local medical assessment. Treatment may involve splinting, a lightweight cast, reduction or surgery depending on the fracture, displacement, existing deformity and previous implants.
Immobilisation is kept as short as safe healing permits because prolonged inactivity can increase weakness, stiffness and loss of bone mass. Physiotherapy after a fracture reassesses joint movement, strength, mobility and the functional effect of the injury.
Caregivers of an infant with osteogenesis imperfecta should receive practical instruction in supported handling, positioning, dressing and transfers. Wide hand support and slow movement reduce concentrated stress on a limb. Overprotection can nevertheless lead to deconditioning, so safe activity and development should remain part of the plan.
Individualised rehabilitation may include muscle strengthening, balance work, supported weight-bearing, mobility training and low-impact aerobic activity. Orthoses, walking aids, adapted seating and wheelchairs can improve safety and independence when correctly fitted.
Bone-Directed Medical Treatment
Adequate calcium, vitamin D, protein and overall nutrition support bone and muscle health. Deficiencies should be corrected, but excessive supplementation is not recommended.
Bisphosphonates such as pamidronate or zoledronic acid are commonly considered by specialist metabolic bone teams, particularly for children with more severe osteogenesis imperfecta, vertebral compression or a substantial fracture burden. They increase bone mineral density and can improve vertebral shape. Evidence that they consistently reduce long-bone fractures or improve mobility is less certain.
The choice of medicine, route, dose and duration depends on age, severity, kidney function, calcium and vitamin D status, fracture history, planned surgery and local regulatory practice. Bisphosphonates do not cure osteogenesis imperfecta or correct an established long-bone deformity.
Several treatments intended to stimulate bone formation remain investigational. Developer-reported results from two Phase 3 studies of the anti-sclerostin antibody setrusumab showed increased bone mineral density, but neither study met its primary fracture-rate endpoint compared with placebo or intravenous bisphosphonate treatment. Setrusumab is not established routine treatment for osteogenesis imperfecta. Ultragenyx Phase 3 results
When Is Orthopaedic Surgery Considered?
Many people with mild osteogenesis imperfecta never need reconstructive surgery. Radiographic appearance alone is not an indication.
Surgery may be considered when recurrent fractures, progressive bowing or instability are interfering with function, causing significant pain or making further deformity likely. Other indications can include a displaced fracture that cannot be managed adequately without fixation, symptomatic nonunion, severe scoliosis or an upper-limb deformity that restricts transfers, wheelchair use or self-care.
Corrective Osteotomy and Intramedullary Rodding
An osteotomy divides and realigns a deformed bone. The corrected bone is usually supported with a rod placed within its central canal. Intramedullary fixation supports more of the bone’s length than a plate positioned on one surface.
Telescopic rods can lengthen as a child grows and are often preferred when the bone dimensions and anatomy allow. Fixed-length rods may be appropriate in adults, near skeletal maturity or when the bone is too small for a telescopic system. Plates and screws used alone can create concentrated stress near the ends of the plate, so they are generally avoided as the sole long-bone implant. Supplemental plating may still have a role in selected complex reconstructions.
Rodding does not make the bone biologically normal. Its purpose is to improve alignment and stability, reduce repeated fractures through a bowed segment and support functional goals.
Limb Lengthening in Osteogenesis Imperfecta
Limb lengthening is not routine treatment for short stature associated with osteogenesis imperfecta. Evidence is limited, and fragile bone, narrow canals, previous implants, joint laxity, deformity and uncertain regenerate formation can make distraction osteogenesis particularly demanding.
When a true, clinically important limb length difference affects gait or function, options may include observation, a shoe lift, correction of the deformity, growth modulation or shortening in selected patients, or carefully planned lengthening. Stable alignment and useful function take priority over achieving equal radiographic length.
Risks, Revision and Recovery
Surgery in osteogenesis imperfecta requires careful positioning, anaesthetic planning, blood-loss management and coordination with rehabilitation and metabolic bone care.
Possible complications include fracture around an implant, rod migration, failure of a telescopic mechanism, loss of fixation, recurrent deformity, growth beyond the supported part of a fixed rod, infection, stiffness and delayed osteotomy healing. Bone nonunion can occur and may require further reconstruction.
Growing children may require another procedure because the bone has lengthened, the anatomy has changed or an implant has migrated. Patients with an existing rod or a complicated previous reconstruction may need assessment under the principles used for revision after limb lengthening or reconstruction.
Recovery and weight-bearing instructions depend on the bone treated, fixation stability, healing, age and baseline mobility. There is no reliable universal recovery timetable.
Osteogenesis Imperfecta in Children and Adults
Fracture frequency is often greatest during childhood and may fall after puberty, but osteogenesis imperfecta remains a lifelong condition. Fractures can continue or become more frequent again in later adulthood.
Adults may also experience vertebral compression, degenerative joint disease, pain, hearing loss, reduced respiratory reserve and difficulties related to old deformities or implants. Transition from paediatric to adult metabolic bone and orthopaedic care should therefore be planned rather than ending when growth stops.
Specialist Osteogenesis Imperfecta Assessment at ILLRC
ILLRC is an Istanbul-based specialist centre focused on limb lengthening, deformity correction and complex limb reconstruction.
Prof. Dr. Halil İbrahim Balcı assesses children, adolescents and adults with osteogenesis imperfecta-related long-bone deformity, recurrent fracture-related instability, limb inequality, previous rodding problems and complex reconstruction needs. His relevant clinical and academic work includes paediatric and adult limb reconstruction, skeletal dysplasia-related deformity, corrective osteotomy, intramedullary fixation and Ilizarov methodology.
Assessment considers the molecular or clinical diagnosis, remaining growth, bone dimensions, mechanical alignment, joint function, fracture history, mobility, previous implants and wider medical risks. ILLRC’s role is orthopaedic. It does not replace ongoing genetic, metabolic bone, respiratory, dental, hearing or paediatric care.
A remote review can identify whether further assessment may be useful, but it cannot confirm that surgery is required or that a particular reconstruction is suitable.
Request a Consultation
WHAT TO KNOW
Frequently Asked Questions
Is osteogenesis imperfecta the same as osteoporosis?
No. Osteoporosis usually describes reduced bone mass and deterioration of bone structure, often acquired with age or another medical condition. Osteogenesis imperfecta is a genetic disorder affecting bone material and connective tissue. A person with osteogenesis imperfecta may also develop osteoporosis, but the terms are not interchangeable.
Can someone have mild osteogenesis imperfecta?
Yes. Mild osteogenesis imperfecta may cause only occasional fractures, blue or grey sclerae, joint hypermobility or hearing loss. Some people are not diagnosed until adolescence or adulthood. Others have severe disease recognised before or shortly after birth.
Can genetic testing confirm osteogenesis imperfecta?
A pathogenic variant in an established osteogenesis imperfecta gene can confirm the molecular diagnosis. Testing usually begins with COL1A1 and COL1A2 or a multigene panel. A negative test does not exclude every case, so results must be interpreted alongside the clinical and radiographic findings.
Do fractures heal normally in osteogenesis imperfecta?
Most fractures unite, but malalignment, refracture and the effects of immobilisation can create further problems. Surgical osteotomies and complex revisions have different healing risks from straightforward fractures and require individual follow-up.
Do bisphosphonates reduce fractures in osteogenesis imperfecta?
Bisphosphonates increase bone mineral density and can improve vertebral shape, especially in children with more severe disease. Evidence for consistent reduction of long-bone fractures varies between studies, medicines and patient groups. They should be prescribed and monitored by a specialist metabolic bone team.
When does a child with osteogenesis imperfecta need rodding surgery?
Rodding may be considered when recurrent fractures, progressive bowing or instability are limiting function or threatening further deformity. It is not required solely because a child has osteogenesis imperfecta. The decision considers growth, bone dimensions, mobility, fracture pattern and rehabilitation goals.
Can bowed limbs be straightened or unequal limbs lengthened in osteogenesis imperfecta?
In selected patients, an osteotomy can straighten an osteogenesis imperfecta-related long-bone deformity, while an intramedullary rod supports the fragile bone. Limb lengthening is considered much less often because bone fragility, narrow canals, joint laxity, previous implants and variable new-bone formation increase treatment complexity. It may be discussed for a clinically important limb inequality that affects gait or function, but alignment, stability and mobility take priority over equalising length.
Does osteogenesis imperfecta still need treatment in adulthood?
Yes. Fracture risk, spinal problems, pain, hearing loss, joint degeneration and respiratory concerns can continue or emerge in adulthood. Adults may also need review of previous implants and bone-directed medication. Follow-up should reflect the person’s symptoms, severity and life stage.
